|
|
Other links at Articles > Diabetes and Endocrinology |
| 1. |
Type 2 Diabetes: The Pathophysiologic Basis of Treatment Design
|
|
|
I am going to talk about the pathophysiology of type 2 diabetes, because most new treatments are now being designed based on our understanding of the pathophysiology. I will discuss some epidemiology, but will spend most of my time on pathophysiology, and conclude with the diagnosis of diabetes and goals of treatment.
|
| 3. |
Obesity and the Human Microbiome
|
|
|
What effect does obesity and its associated diseases have on the composition of the gut microbiota? Current Opinion in Gastroenterology
|
| 5. |
An Overview of Incretin Clinical Trials
|
|
|
This article reviews many of the key incretin clinical trials, with a focus on the efficacy and safety of glucagon-like peptide-1 (GLP-1) receptor agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors compared with placebo and other glucose-lowering agents used as comparators.
|
|
|